PURPOSE: Invasive ductal carcinoma and invasive lobular carcinoma (ILC) represent the major histologic subtypes of invasive breast cancer. They differ with regard to presentation, metastatic spread, and epidemiologic features. To elucidate the genetic basis of these differences, we analyzed copy number imbalances that differentiate the histologic subtypes. EXPERIMENTAL DESIGN: High-resolution genomic profiling of 40 invasive breast cancers using matrix-comparative genomic hybridization with an average resolution of 0.5 Mb was conducted on bacterial artificial chromosome microarrays. The data were subjected to classification and unsupervised hierarchical cluster analyses. Expression of candidate genes was analyzed in tumor samples. RESULTS: The highest discriminating power was achieved when combining the aberration patterns of chromosome arms 1q and 16p, which were significantly more often gained in ILC. These regions were further narrowed down to subregions 1q24.2-25.1, 1q25.3-q31.3, and 16p11.2. Located within the candidate gains on 1q are two genes, FMO2 and PTGS2, known to be overexpressed in ILC relative to invasive ductal carcinoma. Assessment of four candidate genes on 16p11.2 by real-time quantitative PCR revealed significant overexpression of FUS and ITGAX in ILC with 16p copy number gain. Unsupervised hierarchical cluster analysis identified three molecular subgroups that are characterized by different aberration patterns, in particular concerning gain of MYC (8q24) and the identified candidate regions on 1q24.2-25.1, 1q25.3-q31.3, and 16p11.2. These genetic subgroups differed with regard to histology, tumor grading, frequency of alterations, and estrogen receptor expression. CONCLUSIONS: Molecular profiling using bacterial artificial chromosome arrays identified DNA copy number imbalances on 1q and 16p as significant classifiers of histologic and molecular subgroups.
PURPOSE:Invasive ductal carcinoma and invasive lobular carcinoma (ILC) represent the major histologic subtypes of invasive breast cancer. They differ with regard to presentation, metastatic spread, and epidemiologic features. To elucidate the genetic basis of these differences, we analyzed copy number imbalances that differentiate the histologic subtypes. EXPERIMENTAL DESIGN: High-resolution genomic profiling of 40 invasive breast cancers using matrix-comparative genomic hybridization with an average resolution of 0.5 Mb was conducted on bacterial artificial chromosome microarrays. The data were subjected to classification and unsupervised hierarchical cluster analyses. Expression of candidate genes was analyzed in tumor samples. RESULTS: The highest discriminating power was achieved when combining the aberration patterns of chromosome arms 1q and 16p, which were significantly more often gained in ILC. These regions were further narrowed down to subregions 1q24.2-25.1, 1q25.3-q31.3, and 16p11.2. Located within the candidate gains on 1q are two genes, FMO2 and PTGS2, known to be overexpressed in ILC relative to invasive ductal carcinoma. Assessment of four candidate genes on 16p11.2 by real-time quantitative PCR revealed significant overexpression of FUS and ITGAX in ILC with 16p copy number gain. Unsupervised hierarchical cluster analysis identified three molecular subgroups that are characterized by different aberration patterns, in particular concerning gain of MYC (8q24) and the identified candidate regions on 1q24.2-25.1, 1q25.3-q31.3, and 16p11.2. These genetic subgroups differed with regard to histology, tumor grading, frequency of alterations, and estrogen receptor expression. CONCLUSIONS: Molecular profiling using bacterial artificial chromosome arrays identified DNA copy number imbalances on 1q and 16p as significant classifiers of histologic and molecular subgroups.
Authors: Lan Cao; Ahmed Basudan; Matthew J Sikora; Amir Bahreini; Nilgun Tasdemir; Kevin M Levine; Rachel C Jankowitz; Priscilla F McAuliffe; David Dabbs; Sue Haupt; Ygal Haupt; Peter C Lucas; Adrian V Lee; Steffi Oesterreich; Jennifer M Atkinson Journal: Cancer Lett Date: 2019-06-20 Impact factor: 8.679
Authors: Klaus Fellermann; Daniel E Stange; Elke Schaeffeler; Hartmut Schmalzl; Jan Wehkamp; Charles L Bevins; Walter Reinisch; Alexander Teml; Matthias Schwab; Peter Lichter; Bernhard Radlwimmer; Eduard F Stange Journal: Am J Hum Genet Date: 2006-07-12 Impact factor: 11.025
Authors: F Traub; S Schleicher; A Kirschniak; D Zieker; S Kupka; M Weinmann; A Königsrainer; T Kratt Journal: Int J Colorectal Dis Date: 2011-12-16 Impact factor: 2.571
Authors: Victor P Andrade; Mary Morrogh; Li-Xuan Qin; Narciso Olvera; Dilip Giri; Shirin Muhsen; Rita A Sakr; Michail Schizas; Charlotte K Y Ng; Crispinita D Arroyo; Edi Brogi; Agnes Viale; Monica Morrow; Jorge S Reis-Filho; Tari A King Journal: Mol Oncol Date: 2014-12-24 Impact factor: 6.603
Authors: F Bertucci; B Orsetti; V Nègre; P Finetti; C Rougé; J-C Ahomadegbe; F Bibeau; M-C Mathieu; I Treilleux; J Jacquemier; L Ursule; A Martinec; Q Wang; J Bénard; A Puisieux; D Birnbaum; C Theillet Journal: Oncogene Date: 2008-05-19 Impact factor: 9.867
Authors: Sjors M Kas; Julian R de Ruiter; Koen Schipper; Stefano Annunziato; Eva Schut; Sjoerd Klarenbeek; Anne Paulien Drenth; Eline van der Burg; Christiaan Klijn; Jelle J Ten Hoeve; David J Adams; Marco J Koudijs; Jelle Wesseling; Micha Nethe; Lodewyk F A Wessels; Jos Jonkers Journal: Nat Genet Date: 2017-06-26 Impact factor: 38.330
Authors: Mikhail Soloviev; Michelle P Esteves; Fakhria Amiri; Mark R Crompton; Christopher C Rider Journal: PLoS One Date: 2013-02-27 Impact factor: 3.240